polo007 wrote:
Can we get Morton?
Moderator: JaysRule15
GoRapstheoriginal wrote:Yeah I saw that today! That's crazy!
Do we need a all star short stop?
AthensBucks wrote:Lowry is done.
Nurse is below average at best.
Masai is overrated.
I dont get how so many people believe in the raptors,they have zero to chance to win it all.
The Rays missed out on massive revenue last year, most obviously from not having fans at stadiums and fewer games for broadcast partners. Further, they lost out on the benefit of hosting 10 games during the postseason, which ended up costing them money to participate in.
Just as significant, they won’t get their annual revenue sharing check from the big-market teams, estimated a few years ago at $45 million and now possibly higher. With a player payroll that has been averaging around $70 million, that’s a significant hit.
The words general manager Erik Neander uses in talking about navigating the offseason — “flexible” and “responsive” — seem to make it clear there are challenges ahead.
“There’s a lot that comes with everything we’ve experienced over the last eight months and our goal is to be as competitive as possible next year,” Neander said. “But given all of that uncertainty, we’re going to need to be flexible in our approach to accomplishing that.”
They’ve already taken some action, declining options on starter Charlie Morton ($15 million) and catcher Mike Zunino ($4.5 million) while saying they would like to have both back for less. For Morton, that could mean a one-year deal in the $8 million to $12 million range, depending on incentives and/or a 2022 option. For Zunino, maybe half the original option?
Further cuts will require trades, which historically the Rays have not been shy about. They have only three players making more than $5 million in 2021. One, outfielder Yoshi Tsutsugo ($7 million), would seem pretty much untradeable after a rough 2020 debut season after coming over from Japan.
That leaves Kiermaier, who gets $11.5 million in 2021 (plus $12 million in 2022, with either a $13 million option or $2.5 million buyout in 2023); and Snell, who gets $10.5 million in 2021 (plus $12.5 million in 2022 and $16 million in 2023). Both are really good core players, but could end up being dealt.
There is likely to be some other trimming — either by trades or non-tenders at the Dec. 2 deadline from their hefty list of arbitration-eligible players, starting with outfielder Hunter Renfroe, projected by mlbtraderumors.com to get between $3.6-4.3 million. Others projected above $1.6 million include Yonny Chirinos, Ji-Man Choi, Tyler Glasnow, Manuel Margot, Joey Wendle and Ryan Yarbrough. Plus, the Rays are waiting on the Super 2 cutoff date, which could make Diego Castillo and Yandy Diaz eligible.
Another issue is 40-man roster space. Until spring training (when there can be injured list moves), the Rays are carrying four pitchers who won’t be ready to start the season: Jalen Beeks, Chirinos, Brendan McKay, Colin Poche.
AthensBucks wrote:Lowry is done.
Nurse is below average at best.
Masai is overrated.
I dont get how so many people believe in the raptors,they have zero to chance to win it all.
dagger wrote:The Mets may in the market for a 2B now - Robinson Cano tested positive for a performance enhancing drug and is being suspended for the entire 2021 season.